Elizabeth Casiano Evans1, Kristen A Matteson, Francisco J Orejuela, Marianna Alperin, Ethan M Balk, Sherif El-Nashar, Jonathan L Gleason, Cara Grimes, Peter Jeppson, Cara Mathews, Thomas L Wheeler, Miles Murphy. 1. University of Texas Health Science Center San Antonio, San Antonio, Texas; Women & Infants Hospital, Alpert Medical School of Brown University, and the Center for Evidence Based Medicine, Brown University, Providence, Rhode Island; Baylor College of Medicine, Houston, Texas; the University of California, San Diego, San Diego, California; Case Western Reserve University School of Medicine, Cleveland, Ohio; Carilion Clinic, Roanoke, Virginia; Columbia University, College of Physicians and Surgeons, New York, New York; the University of New Mexico, Albuquerque, New Mexico; the University of South Carolina School of Medicine, Greenville, South Carolina; and the Institute for Female Pelvic Medicine and Reconstructive Surgery, North Wales, Pennsylvania.
Abstract
OBJECTIVE: To compare the long-term risks associated with salpingo-oophorectomy with ovarian conservation at the time of benign hysterectomy. DATA SOURCES: MEDLINE, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials were searched from inception to January 30, 2015. We included prospective and retrospective comparative studies of women with benign hysterectomy who had either bilateral salpingo-oophorectomy (BSO) or conservation of one or both ovaries. METHODS OF STUDY SELECTION: Reviewers double-screened 5,568 citations and extracted eligible studies into customized forms. Twenty-six comparative studies met inclusion criteria. Studies were assessed for results, quality, and strength of evidence. TABULATION, INTEGRATION, AND RESULTS: Studies were extracted for participant, intervention, comparator, and outcomes data. When compared with hysterectomy with BSO, prevalence of reoperation and ovarian cancer was higher in women with ovarian conservation (ovarian cancer risk of 0.14-0.7% compared with 0.02-0.04% among those with BSO). Hysterectomy with BSO was associated with a lower incidence of breast and total cancer, but no difference in the incidence of cancer mortality was found when compared with ovarian conservation. All-cause mortality was higher in women younger than age 45 years at the time of BSO who were not treated with estrogen replacement therapy (hazard ratio [HR] 1.41, 95% confidence interval [CI] 1.04-1.92). Coronary heart disease (HR 1.26, 95% CI 1.04-1.54) and cardiovascular death were higher among women with BSO (HR 1.84, 95% CI 1.27-2.68), especially women younger than 45 years who were not treated with estrogen. Finally, there was an increase in the prevalence of dementia and Parkinson disease among women with BSO compared with conservation, especially in women younger than age 50 years. Clinical practice guidelines were devised based on these results. CONCLUSION: Bilateral salpingo-oophorectomy offers the advantage of effectively eliminating the risk of ovarian cancer and reoperation but can be detrimental to other aspects of health, especially among women younger than age 45 years.
OBJECTIVE: To compare the long-term risks associated with salpingo-oophorectomy with ovarian conservation at the time of benign hysterectomy. DATA SOURCES: MEDLINE, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials were searched from inception to January 30, 2015. We included prospective and retrospective comparative studies of women with benign hysterectomy who had either bilateral salpingo-oophorectomy (BSO) or conservation of one or both ovaries. METHODS OF STUDY SELECTION: Reviewers double-screened 5,568 citations and extracted eligible studies into customized forms. Twenty-six comparative studies met inclusion criteria. Studies were assessed for results, quality, and strength of evidence. TABULATION, INTEGRATION, AND RESULTS: Studies were extracted for participant, intervention, comparator, and outcomes data. When compared with hysterectomy with BSO, prevalence of reoperation and ovarian cancer was higher in women with ovarian conservation (ovarian cancer risk of 0.14-0.7% compared with 0.02-0.04% among those with BSO). Hysterectomy with BSO was associated with a lower incidence of breast and total cancer, but no difference in the incidence of cancer mortality was found when compared with ovarian conservation. All-cause mortality was higher in women younger than age 45 years at the time of BSO who were not treated with estrogen replacement therapy (hazard ratio [HR] 1.41, 95% confidence interval [CI] 1.04-1.92). Coronary heart disease (HR 1.26, 95% CI 1.04-1.54) and cardiovascular death were higher among women with BSO (HR 1.84, 95% CI 1.27-2.68), especially women younger than 45 years who were not treated with estrogen. Finally, there was an increase in the prevalence of dementia and Parkinson disease among women with BSO compared with conservation, especially in women younger than age 50 years. Clinical practice guidelines were devised based on these results. CONCLUSION: Bilateral salpingo-oophorectomy offers the advantage of effectively eliminating the risk of ovarian cancer and reoperation but can be detrimental to other aspects of health, especially among women younger than age 45 years.
Authors: Vanessa L Jacoby; Deborah Grady; Jean Wactawski-Wende; JoAnn E Manson; Matthew A Allison; Miriam Kuppermann; Gloria E Sarto; John Robbins; Lawrence Phillips; Lisa W Martin; Mary Jo O'Sullivan; Rebecca Jackson; Rebecca J Rodabough; Marcia L Stefanick Journal: Arch Intern Med Date: 2011-04-25
Authors: Walter A Rocca; Brandon R Grossardt; Mariza de Andrade; George D Malkasian; L Joseph Melton Journal: Lancet Oncol Date: 2006-10 Impact factor: 41.316
Authors: William H Parker; Michael S Broder; Eunice Chang; Diane Feskanich; Cindy Farquhar; Zhimae Liu; Donna Shoupe; Jonathan S Berek; Susan Hankinson; JoAnn E Manson Journal: Obstet Gynecol Date: 2009-05 Impact factor: 7.661
Authors: Morgan E Levine; Ake T Lu; Brian H Chen; Dena G Hernandez; Andrew B Singleton; Luigi Ferrucci; Stefania Bandinelli; Elias Salfati; JoAnn E Manson; Austin Quach; Cynthia D J Kusters; Diana Kuh; Andrew Wong; Andrew E Teschendorff; Martin Widschwendter; Beate R Ritz; Devin Absher; Themistocles L Assimes; Steve Horvath Journal: Proc Natl Acad Sci U S A Date: 2016-07-25 Impact factor: 11.205
Authors: Walter A Rocca; Liliana Gazzuola-Rocca; Carin Y Smith; Brandon R Grossardt; Stephanie S Faubion; Lynne T Shuster; James L Kirkland; Elizabeth A Stewart; Virginia M Miller Journal: Mayo Clin Proc Date: 2016-09-29 Impact factor: 7.616
Authors: Walter A Rocca; Liliana Gazzuola Rocca; Carin Y Smith; Brandon R Grossardt; Stephanie S Faubion; Lynne T Shuster; Elizabeth A Stewart; Michelle M Mielke; Kejal Kantarci; Virginia M Miller Journal: Maturitas Date: 2018-09-14 Impact factor: 4.342
Authors: R van der Meer; C Bakkers; J A Wegdam; T Lettinga; E G Boerma; F Aarts; I H J T de Hingh; R M H Roumen Journal: Int J Colorectal Dis Date: 2022-07-20 Impact factor: 2.796
Authors: Andrea G Kattah; Carin Y Smith; Liliana Gazzuola Rocca; Brandon R Grossardt; Vesna D Garovic; Walter A Rocca Journal: Clin J Am Soc Nephrol Date: 2018-09-19 Impact factor: 8.237
Authors: Frances W Grimstad; Kylie G Fowler; Erika P New; Cecile A Ferrando; Robert R Pollard; Graham Chapman; Meredith Gray; Veronica Gomez Lobo Journal: J Sex Med Date: 2020-07-20 Impact factor: 3.802
Authors: Maya A Wright; Kemi M Doll; Evan Myers; William R Carpenter; Danielle R Gartner; Whitney R Robinson Journal: Am J Obstet Gynecol Date: 2021-06-08 Impact factor: 10.693